Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 8, 2007BloodOpen Access

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801

View Full Paper
Ask AI
Bookmark
Share

Authors

DDDaniel J. DeAngeloDana-Farber Cancer InstituteDYDaohai YuTemple UniversityJJJeffrey L. JohnsonHenry Ford Health System

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

DeAngelo et al. (2007) studied this question.

synapsesocial.com/papers/6a09b013818b42a7b433efb2https://doi.org/10.1182/blood-2006-11-056754
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies2005 · 174 citations
  2. 2Phase II Study of Nelarabine (compound 506U78) in Children and Young Adults With Refractory T-Cell Malignancies: A Report From the Children’s Oncology Group2005 · 322 citations
  3. 3Selective toxicity of deoxyguanosine and arabinosyl guanine for T- leukemic cells1983 · 93 citations
  4. 4PHARMACOLOGIC PURGING OF MALIGNANT T CELLS FROM HUMAN BONE MARROW USING 9-β-D-ARABINOFURANOSYLGUANINE1991 · 21 citations